According to Dermapharm's latest financial reports the company's current earnings are $1.26 Billion USD. In 2023 the company made an earning of $0.17 Billion USD a decrease over its 2022 earnings that were of $0.24 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | $0.22 B | 24.4% |
2023 | $0.17 B | -26.5% |
2022 | $0.24 B | -31.25% |
2021 | $0.35 B | 123.6% |
2020 | $0.15 B | 15.54% |
2019 | $0.13 B | 4.27% |
2018 | $0.13 B | 19.55% |
2017 | $0.10 B |